Epidemiology of HIV/AIDS, hepatitis B, hepatitis C, and tuberculosis among minority injection drug users
about
Comparison of HIV-, HBV-, HCV- and co-infection prevalence between Chinese and Burmese intravenous drug users of the China-Myanmar border regionBlack race as a predictor of poor health outcomes among a national cohort of HIV/AIDS patients admitted to US hospitals: a cohort study.Enhanced tuberculosis case detection among substitution treatment patients: a randomized controlled trialNovel pharmacotherapeutic treatments for cocaine addiction.Chronic liver disease in the Hispanic population of the United States.The STEP into Action study: a peer-based, personal risk network-focused HIV prevention intervention with injection drug users in Baltimore, MarylandPatient characteristics and availability of onsite non-rapid and rapid HIV testing in US substance use disorder treatment programsInjection drug use and the hepatitis C virus: considerations for a targeted treatment approach--the case study of Canada.Injecting drug use is associated with HIV risk perception among Mexican Americans in the Rio Grande Valley of South Texas, USA.A meta-analysis of the hepatitis C virus distribution in diverse racial/ethnic drug injector groupsAttitudes toward methadone among out-of-treatment minority injection drug users: implications for health disparities.Vulnerability to drug-related infections and co-infections among injecting drug users in Budapest, Hungary.Methamphetamine and HIV-Tat alter murine cardiac DNA methylation and gene expression.Intracellular hepatitis B virus increases hepatic cholesterol deposition in alcoholic fatty liver via hepatitis B core protein.Risk prison and hepatitis B virus infection among inmates with history of drug injection in Isfahan, Iran.
P2860
Q28476802-E843B602-C269-44B7-84BC-428DD082A66FQ33492589-CD394173-0ACF-433C-B352-3E21030F7765Q33933639-0899CCA3-2780-45A5-9D16-0C0A8AC51233Q34065088-1874A89D-8DD1-4AB9-8A83-1C75C9F81E2CQ34284875-55D500AE-9654-4BB1-8E9E-EA44E19203A2Q34629993-8FC11D90-B065-4DEA-AFB8-FC68C6131606Q36129595-FC3ABE82-9BB0-4CF2-A737-2EEFDCE3C23CQ36272393-771B4214-0EEF-4F39-ACA6-3F67966661CCQ36498633-0D51B5DB-4DA3-4AD3-B027-51A24EEBD3EFQ37031381-5FD9D6F5-C861-4A14-A4B9-86748739D25AQ37167220-6BE3B48E-6F7A-4665-9717-81CD19B0758CQ37300014-A30CEA2C-4128-4713-8B49-D9B254A2F702Q40607324-9E512473-0E44-44EC-8930-956BE1AACF7CQ45324898-DA96B92D-FAC3-4550-B4A9-818452FE5120Q51872926-97E6A6FE-042A-43C1-927C-43C578C48B92
P2860
Epidemiology of HIV/AIDS, hepatitis B, hepatitis C, and tuberculosis among minority injection drug users
description
2002 nî lūn-bûn
@nan
2002 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Epidemiology of HIV/AIDS, hepa ...... minority injection drug users
@ast
Epidemiology of HIV/AIDS, hepa ...... minority injection drug users
@en
Epidemiology of HIV/AIDS, hepa ...... minority injection drug users
@nl
type
label
Epidemiology of HIV/AIDS, hepa ...... minority injection drug users
@ast
Epidemiology of HIV/AIDS, hepa ...... minority injection drug users
@en
Epidemiology of HIV/AIDS, hepa ...... minority injection drug users
@nl
prefLabel
Epidemiology of HIV/AIDS, hepa ...... minority injection drug users
@ast
Epidemiology of HIV/AIDS, hepa ...... minority injection drug users
@en
Epidemiology of HIV/AIDS, hepa ...... minority injection drug users
@nl
P2860
P1476
Epidemiology of HIV/AIDS, hepa ...... minority injection drug users
@en
P2093
Antonio L Estrada
P2860
P304
P478
117 Suppl 1
P577
2002-01-01T00:00:00Z